0,900  0,002  Monophenol monooxygenase inhibitor
0,900  0,004  15-Lipoxygenase inhibitor
0,863  0,004  Lipoxygenase inhibitor
0,850  0,003  NOS2 expression inhibitor
0,826  0,004  Chemopreventive
0,776  0,014  Transcription factor NF kappa B inhibitor
0,779  0,018  Antiinflammatory
0,763  0,004  UGT1A9 substrate
0,767  0,011  Antineoplastic (lung cancer)
0,753  0,003  Melanin inhibitor
0,764  0,021  Apoptosis agonist
0,743  0,004  Skin whitener
0,745  0,018  Caspase 9 stimulant
0,705  0,005  UGT1A6 substrate
0,717  0,018  Antineoplastic (breast cancer)
0,693  0,005  CYP1A2 inhibitor
0,688  0,006  Antioxidant
0,685  0,005  Free radical scavenger
0,643  0,005  Genotoxic
0,639  0,010  12-Lipoxygenase inhibitor
0,641  0,014  Antihypercholesterolemic
0,626  0,010  Proliferative diseases treatment
0,618  0,010  Cardiovascular analeptic
0,599  0,007  UGT1A1 substrate
0,592  0,011  AR expression inhibitor
0,594  0,015  Radioprotector
0,589  0,010  Nitric oxide antagonist
0,589  0,011  Cardioprotectant
0,581  0,012  Antiosteoporotic
0,577  0,010  Antiprotozoal (Leishmania)
0,570  0,005  UGT1A3 substrate
0,573  0,011  Antineoplastic (brain cancer)
0,571  0,012  Caspase 3 stimulant
0,570  0,017  Bone diseases treatment
0,574  0,026  Antineoplastic (colorectal cancer)
0,569  0,025  Antineoplastic (colon cancer)
0,554  0,011  Hypoglycemic
0,550  0,010  Hypoxia-inducible factor 1 alpha inhibitor
0,547  0,013  Antineoplastic (glioma)
0,548  0,018  Antineoplastic (cervical cancer)
0,536  0,010  UDP-glucuronosyltransferase substrate
0,558  0,036  Cyclophilin D inhibitor
0,558  0,036  Antidiabetic
0,552  0,033  Alzheimer's disease treatment
0,534  0,026  Prostate cancer treatment
0,519  0,016  Antineoplastic (multiple myeloma)
0,521  0,019  Hepatic disorders treatment
0,532  0,034  Antileukemic
0,522  0,035  Antibacterial
0,507  0,020  Cytostatic
0,509  0,022  Spasmolytic
0,487  0,003  Gastritis treatment
0,489  0,007  Antineoplastic (squamous cell carcinoma)
0,487  0,013  Antihypertriglyceridemic
0,486  0,016  Antineoplastic (glioblastoma multiforme)
0,476  0,015  Superoxide dismutase inhibitor
0,454  0,005  Protein-tyrosine phosphatase 1B inhibitor
0,453  0,006  Protein-tyrosine phosphatase inhibitor
0,475  0,031  Antineoplastic (ovarian cancer)
0,480  0,036  Histamine release inhibitor
0,447  0,014  Myocardial infarction treatment
0,473  0,040  Immunosuppressant
0,510  0,078  Alpha-glucosidase inhibitor
0,433  0,018  Vasodilator
0,442  0,028  Chemoprotective
0,436  0,024  Antiamyloidogenic
0,462  0,057  TNF expression inhibitor
0,431  0,032  Lipoprotein disorders treatment
0,428  0,030  ICAM1 expression inhibitor
0,415  0,022  Antidiabetic symptomatic
0,400  0,008  NOS3 expression enhancer
0,419  0,028  Antidiabetic (type 2)
0,400  0,009  Lipid peroxidase inhibitor
0,420  0,030  Sensitization
0,401  0,011  Platelet adhesion inhibitor
0,404  0,015  UGT1A4 substrate
0,424  0,036  Antineoplastic (melanoma)
0,393  0,004  Antibacterial (Helicobacter pylori)
0,397  0,012  Antihypotensive
0,406  0,026  Antipyretic
0,390  0,014  Antineoplastic (carcinoma)
0,378  0,006  5-Lipoxygenase inhibitor
0,410  0,039  CYP2C19 substrate
0,381  0,011  VCAM1 expression inhibitor
0,386  0,017  Antimutagenic
0,372  0,005  Heat shock protein 90 antagonist
0,396  0,032  UGT2B4 substrate
0,371  0,012  Topoisomerase II inhibitor
0,383  0,038  Cytotoxic
0,354  0,009  Neurotrophic factor enhancer
0,348  0,006  Antihemorrhagic
0,371  0,030  Antineoplastic (renal cancer)
0,430  0,089  Antineoplastic (solid tumors)
0,370  0,029  Antineoplastic (osteosarcoma)
0,357  0,018  Hepatoprotectant
0,337  0,003  Papain-like protease (SARS coronavirus) inhibitor
0,363  0,040  Antineoplastic (non-small cell lung cancer)
0,364  0,049  NOS3 expression inhibitor
0,387  0,074  Antiprotozoal
0,343  0,031  Antiulcerative
0,376  0,070  Ulceration
0,358  0,055  CYP2D6 substrate
0,374  0,077  CYP2C19 inhibitor
0,298  0,005  Aromatase inhibitor
0,307  0,016  UGT2B15 substrate
0,347  0,057  Apoptosis antagonist
0,322  0,038  Antiparasitic
0,325  0,042  Hypolipemic
0,336  0,060  Respiratory analeptic
0,300  0,028  Non-steroidal antiinflammatory agent
0,289  0,020  Amylase inhibitor
0,313  0,044  Vascular (periferal) disease treatment
0,313  0,047  Antineoplastic (lymphoma)
0,291  0,034  Antihelmintic
0,273  0,020  Heat shock protein 90 alpha antagonist
0,336  0,083  CYP3A4 substrate
0,283  0,032  P-glycoprotein inhibitor
0,319  0,072  Antifungal
0,338  0,093  Antiobesity
0,297  0,053  Antineoplastic (liver cancer)
0,291  0,047  Antineoplastic (lymphocytic leukemia)
0,247  0,007  Estrogen receptor beta antagonist
0,248  0,009  Estrogen antagonist
0,304  0,067  Antineoplastic (pancreatic cancer)
0,260  0,024  Tubulin antagonist
0,253  0,020  LDLR expression enhancer
0,288  0,059  Transcription factor STAT3 inhibitor
0,273  0,044  Antineoplastic enhancer
0,255  0,027  MAO inhibitor
0,301  0,078  Antineoplastic (small cell lung cancer)
0,280  0,056  Antiglaucomic
0,320  0,101  CYP2C9 inhibitor
0,251  0,036  CYP2B6 inhibitor
0,226  0,011  Beta amyloid protein antagonist
0,265  0,053  Amyloid beta aggregation inhibitor
0,267  0,062  Angiogenesis stimulant
0,235  0,035  Diabetic nephropathy treatment
0,204  0,005  Lipase inhibitor
0,299  0,100  Antiprotozoal (Plasmodium)
0,291  0,094  Antithrombotic
0,241  0,045  UGT2B7 substrate
0,298  0,108  CYP2C9 substrate
0,197  0,008  Postmenopausal disorders treatment
0,278  0,089  Streptokinase A inhibitor
0,196  0,008  Estrogen receptor alpha antagonist
0,207  0,020  Farnesoid X receptor antagonist
0,198  0,015  Topoisomerase II alpha inhibitor
0,270  0,094  Analeptic
0,181  0,005  Ca(v)3.1 blocker
0,205  0,032  Acetylcholinesterase inhibitor
0,200  0,029  MAO A inhibitor
0,179  0,009  Estrogen agonist
0,185  0,015  Dementia treatment
0,184  0,015  Beta glucuronidase inhibitor
0,178  0,011  Electron transport complex I inhibitor
0,252  0,085  Transcription factor STAT inhibitor
0,242  0,076  Platelet antagonist
0,190  0,026  MAO B inhibitor
0,290  0,127  Antipruritic, allergic
0,178  0,016  Vascular dementia treatment
0,196  0,037  Antidiarrheal
0,180  0,022  Coagulant
0,258  0,102  CTGF expression inhibitor
0,182  0,028  Antifungal (Cryptococcus)
0,187  0,033  DNA polymerase I inhibitor
0,235  0,082  Antineoplastic (sarcoma)
0,196  0,045  Phospholipase A2 inhibitor
0,214  0,065  Carcinogenic
0,192  0,043  UGT2B10 substrate
0,168  0,022  Mediator release inhibitor
0,162  0,018  Urease inhibitor
0,176  0,033  Topoisomerase I inhibitor
0,147  0,006  Neuraminidase inhibitor
0,161  0,020  Breast cancer-resistant protein inhibitor
0,243  0,105  Antihypoxic
0,149  0,011  Ornithine decarboxylase inhibitor
0,178  0,042  SULT1A3 substrate
0,205  0,068  Abortion inducer
0,182  0,049  Interferon gamma antagonist
0,161  0,029  Antineoplastic antibiotic
0,158  0,026  TRPA1 agonist
0,210  0,079  Antimitotic
0,164  0,036  Glutathione S-transferase substrate
0,166  0,037  Cholesterol synthesis inhibitor
0,173  0,046  Cyclooxygenase 1 inhibitor
0,147  0,021  Actinic keratosis treatment
0,249  0,124  Angiogenesis inhibitor
0,178  0,055  Antiviral (Influenza A)
0,178  0,057  Cholinergic
0,141  0,020  Antiviral (SARS coronavirus)
0,141  0,020  Antiviral (Coronavirus)
0,178  0,058  Antiviral (Herpes)
0,131  0,018  Keratolytic
0,134  0,022  SULT1E1 substrate
0,121  0,009  Estrogen receptor beta agonist
0,144  0,034  HDL-cholesterol increasing
0,200  0,089  Nitric-oxide synthase stimulant
0,154  0,045  Cyclooxygenase 3 inhibitor
0,116  0,008  Leukotriene B4 antagonist
0,271  0,164  Antiparkinsonian
0,122  0,018  Bile acid receptor antagonist
0,178  0,075  Mutagenic
0,127  0,026  ABCA1 expression enhancer
0,122  0,022  Alpha 2d adrenoreceptor antagonist
0,185  0,086  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,137  0,039  Alpha 2c adrenoreceptor antagonist
0,207  0,110  DNA damaging
0,153  0,057  Bone formation stimulant
0,113  0,017  Leukotriene antagonist
0,225  0,129  Antimycobacterial
0,166  0,070  Arachidonic acid antagonist
0,229  0,133  GST M1-1 substrate
0,139  0,044  Microtubule formation inhibitor
0,124  0,031  UGT2B11 substrate
0,229  0,137  CYP3A4 inhibitor
0,103  0,013  5 Hydroxytryptamine 2A agonist
0,111  0,023  Peroxisome proliferator-activated receptor gamma agonist
0,148  0,061  Neurotrophic factor
0,101  0,016  Neuraminidase (influenza) inhibitor
0,093  0,009  Transcription factor RelA inhibitor
0,123  0,043  Sulfotransferase substrate
0,131  0,050  Cystathionine beta-synthase inhibitor
0,125  0,044  UGT2B1 substrate
0,154  0,073  UGT2B9 substrate
0,151  0,071  Antiischemic, cerebral
0,105  0,027  Na+ K+ transporting ATPase inhibitor
0,132  0,059  Antineoplastic (uterine cancer)
0,140  0,067  Alkaline phosphatase inhibitor
0,088  0,015  Fatty acid synthase inhibitor
0,110  0,039  Androgen antagonist
0,105  0,035  Phosphodiesterase 4D inhibitor
0,188  0,118  RNA-directed DNA polymerase inhibitor
0,195  0,130  Huntington's disease treatment
0,200  0,135  Tyrosine 3 hydroxylase inhibitor
0,134  0,070  Antiacne
0,110  0,046  Prolactin inhibitor
0,085  0,022  Aldose reductase inhibitor
0,075  0,011  Vanilloid 2 antagonist
0,075  0,013  Glucose-6-phosphate translocase inhibitor
0,163  0,102  Antiviral (Influenza)
0,116  0,056  Choleretic
0,111  0,052  Gastric antisecretory
0,086  0,027  Beta tubulin antagonist
0,193  0,134  Antituberculosic
0,089  0,030  Phosphodiesterase VI inhibitor
0,188  0,130  Antiprotozoal (Trypanosoma)
0,115  0,059  Chelator
0,071  0,015  Potassium channel Kv1.3 blocker
0,135  0,079  Protein kinase stimulant
0,101  0,047  Thioredoxin inhibitor
0,078  0,026  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,165  0,113  Insulin sensitizer
0,072  0,023  Alpha tubulin antagonist
0,090  0,041  Alpha 2a adrenoreceptor antagonist
0,085  0,038  SULT1A2 substrate
0,112  0,065  SULT1A1 substrate
0,154  0,107  Antineoplastic (bone cancer)
0,097  0,051  Alpha 2 adrenoreceptor antagonist
0,062  0,017  Cathepsin L2 inhibitor
0,081  0,037  Leukotriene synthesis inhibitor
0,214  0,170  Sodium/bile acid cotransporter inhibitor
0,097  0,054  Antiviral (Rhinovirus)
0,063  0,024  Pregnane X receptor antagonist
0,044  0,008  Estrogen-related receptor beta antagonist
0,043  0,010  Leukotriene B4 receptor 1 antagonist
0,037  0,005  Leukotriene B4 receptor 2 antagonist
0,104  0,072  Mucolytic
0,103  0,072  Alpha 2b adrenoreceptor antagonist
0,133  0,103  Prostatic (benign) hyperplasia treatment
0,076  0,047  CDC25A inhibitor
0,065  0,036  Transcription factor AP-1 inhibitor
0,090  0,061  Antiviral (Hepatitis A)
0,035  0,007  Inosine monophosphate dehydrogenase 1 inhibitor
0,077  0,050  Antibiotic
0,099  0,072  AMP-activated protein kinase stimulant
0,078  0,052  NAD(P)H dehydrogenase (quinone) inhibitor
0,118  0,094  Vanilloid 1 agonist
0,056  0,032  5 Hydroxytryptamine 2 agonist
0,091  0,070  Xanthine oxidase inhibitor
0,116  0,095  Antifungal enhancer
0,091  0,070  Creatine kinase inhibitor
0,158  0,137  Antialcoholic
0,042  0,021  Retinoid X receptor agonist
0,075  0,055  Antitreponemal
0,044  0,025  DNA gyrase subunit A inhibitor
0,059  0,040  Ca(v)3.2 blocker
0,131  0,113  Ca2+-transporting ATPase inhibitor
0,026  0,009  Retinoic acid alpha receptor antagonist
0,161  0,146  Immunostimulant
0,029  0,014  Sodium/glucose cotransporter 2 inhibitor
0,039  0,024  Retinoid X receptor antagonist
0,037  0,022  Retinoid X alpha receptor agonist
0,036  0,022  Estrogen receptor alpha agonist
0,069  0,056  Peroxisome proliferator-activated receptor gamma antagonist
0,129  0,118  Prostate disorders treatment
0,185  0,176  CYP1A2 substrate
0,025  0,019  Sodium/glucose cotransporter inhibitor
0,018  0,013  Retinoic acid receptor antagonist
0,065  0,061  Histone deacetylase stimulant
0,065  0,061  Histone deacetylase SIRT1 stimulant
0,058  0,053  Dopamine D1 antagonist
0,113  0,108  Cyclooxygenase inhibitor
0,085  0,082  Antiemetic
0,146  0,143  Aldehyde oxidase inhibitor
0,117  0,114  Thrombolytic
0,015  0,013  Antibiotic Tetracycline-like
0,087  0,086  Expectorant

